![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd EHDN 2018 Plenary Meeting, Vienna, Austria, Programme and Abstracts - ()] Clinical therapeutics - J06â A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-02545920 in huntington disease (amaryllis)
Delnomdedieu, Marielle, Tan, Ye, Ogden, Adam, Berger, Zdenek, Reilmann, RalfYear:
2018
DOI:
10.1136/jnnp-2018-ehdn.266
File:
PDF, 66 KB
2018